E2F5 and cancer: TRIAD1 was shown to facilitate the degradation of MDM2, increasing the apoptotic activity of p53 (56), while CHES1 downregulates the expression of the oncogenic proteins PIM2 and E2F5 in cancer cells (71, 72).